# Smoking

#### Highlights<br/>
- Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) [Lippi et al](https://doi.org/10.1016/j.ejim.2020.03.014)<br/>

#### Articles<br/>
|Date|Authors|Title|LOE & Sample|Matches|
|----|----|----|----|----|
|2020|Liu et al|[Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease](https://doi.org/10.1097/cm9.0000000000000775)<br/>Chin Med J (Engl)|IV. Prevalence Study<br/><br/>In the present study, 78 patients with COVID-19 associated pneumonia included 39 males and 39 females.|Personal data included sex, age, epidemiological history, history of smoking, and comorbidities [e.g., chronic obstructive pulmonary disease (COPD), cancer, hypertension and/or diabetes].<br/><br/>The proportion of patients with a history of smoking was significantly higher in the progression group compared to the improvement/stabilization group, suggesting that smoking is associated with disease progression.|
|2020-02-05|He et al|[Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV](https://doi.org/10.1101/2020.02.03.20020206)<br/>medrxiv|IV. Other|Moreover, based on the expression of ACE2 in smoking individuals, we inferred that long-term smoking might be a risk factor for 2019-nCoV.|
|2020-03-16|Lippi et al|[Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)](https://doi.org/10.1016/j.ejim.2020.03.014)<br/>European Journal of Internal Medicine|I. Systematic Review<br/><br/>Therefore, 5 studies could finally be included in our meta-analysis, totaling 1399 COVID-19 patients, 288 of whom (20.6%) with severe disease     .|Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)|
|2020-03-23|Leung et al|[ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19](https://doi.org/10.1101/2020.03.18.20038455)<br/>medrxiv|III-3. Time Series Analysis<br/><br/>As of March 13, 2020, there have been 144,064 laboratory-confirmed cases of COVID-19 worldwide with 5,397 deaths worldwide .|Because individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of severe COVID19, we determined whether ACE2 expression in the lower airways was related to COPD and cigarette smoking.|
|2020-03-23|Luo et al|[Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China](https://doi.org/10.1101/2020.03.19.20033175)<br/>medrxiv|IV. Other|History of smoking or drinking was not associated with clinical outcome.|
|2020-03-24|Emami et al|[Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/)<br/>Arch Acad Emerg Med|I. Systematic Review<br/><br/>RESULTS: The data of 76993 patients presented in 10 articles were included in this study.|However, factors such as amount of smoking, the duration of smoking, and the duration of smoking cessation also play a role.|
|2020-03-27|Alqahtani et al|[Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis](https://doi.org/10.1101/2020.03.25.20043745)<br/>medrxiv|I. Systematic Review<br/><br/>A total of 15 studies met the inclusion criteria, which included a total of 2473 confirmed COVID-19 patients.|Concerning smoking and COVID-19, our data showed a pooled prevalence of 9% current smokers, (95% CI, 4%-14%), lower than the reported prevalence of smoking in China that was 25.2% (25.<br/><br/>The impact of smoking history on vulnerability to COVID-19 has been explored but there is limited data on the contribution of tobacco smoking to the spread of and poor outcome in COVID-19.|
|2020-03-31|Smith et al|[Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2](https://doi.org/10.1101/2020.03.28.013672)<br/>biorxiv|III-3. Time Series Analysis<br/><br/>Viral RNA has been detected in stool samples from patients with COVID-19 19 , and gastrointestinal symptoms have been reported in a subset of affected individuals 12 , suggesting a potential alternate route for SARS-CoV-2 transmission.|Cigarette smoking is strongly associated with adverse outcomes from COVID-19 12,23 .|

# Pregnancy

#### Highlights<br/>
- Three (25%) women died during pregnancy. [Favre et al](https://doi.org/10.1016/s0140-6736%2820%2930311-1)<br/>

#### Articles<br/>
|Date|Authors|Title|LOE & Sample|Matches|
|----|----|----|----|----|
|2020|Chen et al|[Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases](https://doi.org/10.3760/cma.j.cn112151-20200225-00138)<br/>Zhonghua Bing Li Xue Za Zhi|IV. Other|Conclusions: The clinical characteristics of pregnant women with 2019-nCoV infection in late pregnancy are similar to those of non-pregnant patients, and no severe adverse pregnancy outcome is found in the 3 cases of our observation.|
|2020-02-24|Rasmussen et al|[Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know](https://doi.org/10.1016/j.ajog.2020.02.017)<br/>American Journal of Obstetrics and Gynecology|IV. Other|44 , nine women diagnosed with COVID-19 during 306 the third trimester of pregnancy were reported.<br/><br/> Delivery and pregnancy termination decisions should be based on gestational age, maternal condition, and fetal stability, and maternal wishes.|
|2020-02-28|Favre et al|[2019-nCoV epidemic: what about pregnancies?](https://doi.org/10.1016/s0140-6736%2820%2930311-1)<br/>The Lancet|IV. Other|Three (25%) women died during pregnancy.|
|2020-03-13|Chen et al|[Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records](https://doi.org/10.1016/s0140-6736%2820%2930360-3)<br/>The Lancet|IV. Other|Neonate 4 had a birthweight of 1880 g and the pregnancy was complicated by pre-eclampsia.|
|2020-03-23|Panahi et al|[Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092922/)<br/>Arch Acad Emerg Med|IV. Other|Regarding neonatal outcomes, no information is available on teratogenicity and transmission of infection via placenta in the first, second and third trimesters of pregnancy, during normal vaginal delivery and through breast milk.<br/><br/>No antiviral medications were given to mothers during pregnancy.|
|2020-03-25|Di Mascio et al|[Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis](https://doi.org/10.1016/j.ajogmf.2020.100107)<br/>American Journal of Obstetrics & Gynecology MFM|I. Systematic Review<br/><br/>Results 19 studies including 79 women were eligible for this systematic review: 41 pregnancies (51.9%) affected by COVID-19, 12 (15.2%) by MERS, and 26 (32.9%) by SARS.|The pregnancy outcomes observed were: 135|
|2020-06-30|Liu et al|[Why are pregnant women susceptible to COVID-19? An immunological viewpoint](https://doi.org/10.1016/j.jri.2020.103122)<br/>Journal of Reproductive Immunology|IV. Prevalence Study<br/><br/>A total of eighteen pregnant women infected with NCP (mean age: 30 years) had one or two common clinical symptoms, such as fever, cough, cholecystitis, sore throat, and diarrhea.|Further studies are warranted to investigate the pregnant women with COVID-19 in the first and second trimester and follow-up the pregnancy outcomes and postnatal development of the fetus.<br/><br/>Timely intervention with individualized approach should be given to these women according to the severity of the disease and advancement of pregnancy (the trimester of the pregnancy).|

# Incubation period

#### Highlights<br/>
- In (C), the incubation period was 5 days. [Hellewell et al](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097845/)<br/>

#### Articles<br/>
|Date|Authors|Title|LOE & Sample|Matches|
|----|----|----|----|----|
|2020|Zhang et al|[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing](https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0013)<br/>Zhonghua Jie He He Hu Xi Za Zhi|IV. Other|The incubation period was 1 to 6 days.|
|2020|Cho et al|[Effectiveness for the Response to COVID-19: The MERS Outbreak Containment Procedures](https://doi.org/10.24171/j.phrp.2020.11.1.01)<br/>Osong Public Health and Research Perspectives|IV. Other|The incubation period was 4.8 days.|
|2020|Xu et al|[Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV](https://doi.org/10.3390/v12020244)<br/>Viruses|IV. Prevalence Study<br/><br/>Among the 8,866 patients who have been confirmed with COVID-19, nearly half of the patients have been aged 50 years or older (47.7%) .|The incubation period of SARS is 1-4 days .|
|2020-02-11|Hellewell et al|[Feasibility of controlling 2019-nCoV outbreaks by isolation of cases and contacts](https://doi.org/10.1101/2020.02.08.20021162)<br/>medrxiv|IV. Computer Model|In C, the incubation period was 5 days.|
|2020-02-28|Hellewell et al|[Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097845/)<br/>Lancet Glob Health|IV. Computer Model|In (C), the incubation period was 5 days.|
|2020-03-03|Yang et al|[Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China](https://doi.org/10.1101/2020.02.28.20028068)<br/>medrxiv|III-3. Time Series Analysis<br/><br/>A total of 55 consecutive patients with laboratory-confirmed COVID-19 were enrolled in this study.|The mean incubation period of COVID-19 was .|
|2020-03-09|Anderson et al|[How will country-based mitigation measures influence the course of the COVID-19 epidemic?](https://doi.org/10.1016/s0140-6736%2820%2930567-5)<br/>The Lancet|IV. Other|The incubation period for COVID-19 is about 5-6 days.|
|2020-03-10|Gao et al|[The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen,Hubei,China](https://doi.org/10.1101/2020.03.07.20031393)<br/>medrxiv|IV. Prevalence Study<br/><br/>Findings: Of the 213 cases (108 men and 105 women) , 88 (41%) had exposure to Wuhan.|It was reported that the incubation period was 4-7 days.|
|2020-03-16|Zhang et al|[Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series](https://doi.org/10.1101/2020.03.12.20034686)<br/>medrxiv|IV. Prevalence Study<br/><br/>In this case series, data from 34 paediatric patients with COVID-19 were analyzed, including 14 male patients (41.18%) and 20 female patients (58.82%).|The median incubation period was 10.50 (7.75 - 25.25) days.|
|2020-04-01|Zhu et al|[Transmission Dynamics and Control Methodology of COVID-19: a Modeling Study](https://doi.org/10.1101/2020.03.29.20047118)<br/>medrxiv|III-3. Time Series Analysis<br/><br/>3) , there are no more than 5 new cases every day from Dec 8 to Dec 28.|The mean incubation period is 5.2 days .|

# Economic consequences

#### Highlights<br/>
- 2, 3 The economic and psychological impact of the epidemic is enormous. [Lazzerini et al](https://doi.org/10.1016/s2214-109x%2820%2930110-8)<br/>

#### Articles<br/>
|Date|Authors|Title|LOE & Sample|Matches|
|----|----|----|----|----|
|2020|Chen et al|[Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China](https://doi.org/10.1097/cm9.0000000000000782)<br/>Chin Med J (Engl)|IV. Other|COVID-19 is causing great public health and economic losses in China.|
|2020-02-05|Ai et al|[Population movement, city closure and spatial transmission of the 2019-nCoV infection in China](https://doi.org/10.1101/2020.02.04.20020339)<br/>medrxiv|IV. Prevalence Study|Since the political and economic effects were not considered, further 288 studies on secondary impacts of the measure, like socioeconomic impacts, were also 289 warranted.|
|2020-02-24|El Zowalaty et al|[From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075990/)<br/>One Health|IV. Prevalence Study<br/><br/>However, it was recently reported that the Chinese Centers for Disease Control and Prevention isolated SARS-CoV-2 from 33 samples out of 585 environmental samples collected from Huanan Seafood Market .|In conclusion, SARS-CoV-2 which causes COVID-19 is continuing to cause global fears, psychological distress, economic losses and negative impacts on several human activities including industry and mobility.|
|2020-03-03|Yang et al|[The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China](https://doi.org/10.1016/j.jaut.2020.102434)<br/>Journal of Autoimmunity|IV. Prevalence Study<br/><br/>In Wang's study , of the 36 patients in the ICU, four patients received high-flow oxygen therapy, 15 patients received non-invasive ventilation, and 17 patients received invasive ventilation (four patients switched to ECMO).|The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally.|
|2020-03-05|Peters et al|[Understanding the emerging coronavirus: what it means for health security and infection prevention](https://doi.org/10.1016/j.jhin.2020.02.023)<br/>Journal of Hospital Infection|IV. Prevalence Study<br/><br/>50 Super spreading individuals were found to have a major impact in the previous MERS, SARS, and Ebola pandemics.|Impact can be assessed in different ways, including global morbidity, mortality, and economic burden, and geopolitical implications.|
|2020-03-18|Lazzerini et al|[COVID-19 in Italy: momentous decisions and many uncertainties](https://doi.org/10.1016/s2214-109x%2820%2930110-8)<br/>The Lancet Global Health|IV. Other|2, 3 The economic and psychological impact of the epidemic is enormous.|
|2020-03-24|Wingfield et al|[Tackling two pandemics: a plea on World Tuberculosis Day](https://doi.org/10.1016/s2213-2600%2820%2930151-x)<br/>The Lancet Respiratory Medicine|IV. Prevalence Study<br/><br/>Children are less severely affected by COVID-19, whereas 1·1 million children had tuberculosis disease in 2018, of whom 200 000 died.|3, 4 And, as we are discovering for COVID-19, both diseases have considerable social impact-including stigma, discrimination, and isolation-in addition to the economic impact from country productivity losses and catastrophic costs to individuals and households.|
|2020-03-24|magal et al|[Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany](https://doi.org/10.1101/2020.03.21.20040154)<br/>medrxiv|IV. Computer Model|The consequences of late public interventions may have severe consequences for the epidemic outcome (as illustrated in Figure 6 in ).|
|2020-03-27|Lee et al|[Epidemic preparedness in urban settings: new challenges and opportunities](https://doi.org/10.1016/s1473-3099%2820%2930249-8)<br/>The Lancet Infectious Diseases|IV. Prevalence Study|The outbreaks of these diseases resulted in wide ranging socioeconomic consequences, including loss of lives and disruption to trade and travel.|
|2020-04-30|Shah et al|[A commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”](https://doi.org/10.1016/j.ijsu.2020.03.001)<br/>International Journal of Surgery|IV. Other|The consequences of the COVID-19 outbreak are not only limited to human infection and deaths, but also have associated social repercussions, including racial and xenophobic attacks and adverse economic implications, which have badly affected the travel industry , disrupted the supply chain and stock exchanges , and slowed the global economy .|

